The demethyltransferase FTO has been found to exert a pro-carcinogenic effect in acute myeloid leukemia by regulating m6A levels on the mRNA of downstream target genes, such as ASB2 and RARA22. The gene discussed is ASB2; the disease is acute myeloid leukemia.